Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma
Rescripting With vs. Without Prior Stabilization in PTSD Following Early Chronic Interpersonal Trauma
1 other identifier
interventional
61
1 country
1
Brief Summary
Imagery Rescripting (IR)is a promising treatment for PTSD in adult survivors of early, chronic, interpersonal trauma (e.g. Smucker \& Dancu, 1999). So far, this protocol has not been investigated within a controlled setting with patients with PTSD following early, chronic, interpersonal trauma. The aim of the proposed study is to 1. investigate the efficacy of Imagery Rescripting and 2. check whether the efficacy of Imagery Rescripting can be improved by adding a stabilization phase (Skills training in affective and interpersonal regulation, STAIR) prior to this treatment. In a randomized controlled trial three conditions will be compared:
- 1.Imagery Rescripting
- 2.STAIR + Imagery Rescripting
- 3.Wait-list control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 25, 2011
CompletedFirst Posted
Study publicly available on registry
November 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedDecember 9, 2021
December 1, 2021
6 years
October 25, 2011
December 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline in Clinician-Administered PTSD Scale (CAPS) at 8 weeks
comparison STAIR vs ImRs vs WL
baseline and 8 weeks
Change from Baseline in Posttraumatic Diagnostic Scale (PDS) at 8 weeks
comparison STAIR vs ImRs vs WL
baseline and 8 weeks
Secondary Outcomes (25)
Change from Baseline in Beck Depression Inventory (BDI)at 8 weeks
baseline and 8 weeks
Change from Baseline in Buss-Durkee Hostility Inventory (BDHI)at 8 weeks
baseline and 8 weeks
Change from Baseline in Inventory of Interpersonal Problems (IIP)at 8 weeks
baseline and 8 weeks
Change from Baseline in Dissociation Questionnaire (DIS-Q)at 8 weeks
baseline and 8 weeks
Change from Baseline in WHO-Quality of Life(WHO-QL)at 8 weeks
baseline and 8 weeks
- +20 more secondary outcomes
Study Arms (3)
Imagery Rescripting
EXPERIMENTALSTAIR plus Imagery Rescripting
ACTIVE COMPARATORWait-list control
NO INTERVENTIONParticipants from this arm are randomized to the two active conditions after 8 weeks of waiting.
Interventions
This intervention is comprised of 16 sessions (twice a week) of trauma-focused imagery rescripting
A two-phased treatment. Phase 1 is comprised of 8 (weekly) sessions of Skills Training in Affective and Interpersonal Skills (STAIR). Phase 2 consists of 16 sessions (twice weekly) of trauma-focused imagery rescripting.
Eligibility Criteria
You may qualify if:
- a full diagnosis of post-traumatic stress disorder (PTSD) according to DSM-IV
- having experienced repeated or chronic interpersonal trauma by care-takers or authority figures before the age of 15
- between the age of 18 and 65 years
- sufficient fluency of Dutch to complete treatment and research-protocol
- participants using prescribed anti-depressant medication are required to be on a stable dose for at least 6 weeks before the beginning of treatment and remain on this dose throughout the treatment
You may not qualify if:
- psychosis
- bipolar disorder
- significant cognitive impairment
- substance dependence
- current use of benzodiazepines
- severe suicidal ideation or life-threatening automutilation
- current trauma or threat
- unstable living circumstances
- antisocial personality disorder
- primary diagnosis of borderline personality disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Amsterdam
Amsterdam, 1018 XA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merel Kindt, Prof dr
University of Amsterdam
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Experimental and Clinical Psychology
Study Record Dates
First Submitted
October 25, 2011
First Posted
November 4, 2011
Study Start
October 1, 2011
Primary Completion
October 1, 2017
Study Completion
October 1, 2017
Last Updated
December 9, 2021
Record last verified: 2021-12